A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis (Q33899901)

29 July 2017

A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis (English)

1 reference

29 July 2017

phase I clinical trial

0 references

multiple sclerosis

0 references

phase II clinical trial

0 references

1 reference

J M Burton

1

1 reference

29 July 2017

S Kimball

2

1 reference

29 July 2017

R Vieth

3

1 reference

29 July 2017

A Bar-Or

4

1 reference

29 July 2017

H-M Dosch

5

1 reference

29 July 2017

R Cheung

6

1 reference

29 July 2017

D Gagne

7

1 reference

29 July 2017

C D'Souza

8

1 reference

29 July 2017

M Ursell

9

1 reference

29 July 2017

P O'Connor

10

1 reference

29 July 2017

language of work or name

English

0 references

publication date

28 April 2010

1 reference

29 July 2017

1 reference

29 July 2017

74

1 reference

29 July 2017

23

1 reference

29 July 2017

1852-1859

1 reference

Vitamin D as an immune modulator in multiple sclerosis, a review

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882221

Safety of vitamin D3 in adults with multiple sclerosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882221

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882221

A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882221

Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882221

Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882221

Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882221

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882221

Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882221

Elevated serum inflammatory markers in post-poliomyelitis syndrome

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882221

Abnormal T-cell reactivities in childhood inflammatory demyelinating disease and type 1 diabetes.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882221

Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882221

The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. 1994 [classical article].

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882221

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2882221

25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis

29 October 2018

1 reference

12 December 2020

Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation, and other variables

1 reference

12 December 2020

A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis

1 reference

12 December 2020

Geographic distribution of multiple sclerosis

1 reference

12 December 2020

Dietary calcium is a major factor in 1,25-dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice

1 reference

12 December 2020

Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis

1 reference

12 December 2020

The urgent need to recommend an intake of vitamin D that is effective

1 reference

12 December 2020

10.1212/WNL.0B013E3181E1CEC2

Identifiers

DOI

1 reference

29 July 2017

1 reference

29 July 2017

1 reference